Point72 Asset Management
FHTX icon

Point72 Asset Management’s Foghorn Therapeutics FHTX Stock Holding History

Point72 Asset Management’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$132K Sell
27,646
-34,322
-55% -$188K ﹤0.01% 3580
2025
Q4 		$335K Sell
61,968
-309,065
-83% -$1.4M ﹤0.01% 3429
2025
Q3 		$1.81M Sell
371,033
-297,686
-45% -$1.58M ﹤0.01% 1478
2025
Q2 		$3.14M Buy
668,719
+43,502
+7% +$182K 0.01% 1131
2025
Q1 		$2.28M Sell
625,217
-9,544
-2% -$43.5K 0.01% 1204
2024
Q4 		$3M Buy
634,761
+235,059
+59% +$1.71M 0.01% 1105
2024
Q3 		$3.72M Sell
399,702
-6,939
-2% -$50.2K 0.01% 965
2024
Q2 		$2.34M Sell
406,641
-30,728
-7% -$183K 0.01% 1053
2024
Q1 		$2.93M Sell
437,369
-102,631
-19% -$570K 0.01% 1143
2023
Q4 		$3.48M Buy
540,000
+255,145
+90% +$1.1M 0.01% 1042
2023
Q3 		$1.42M Buy
284,855
+5,700
+2% +$43.9K ﹤0.01% 1227
2023
Q2 		$1.97M Buy
+279,155
New +$1.95M 0.01% 1042
2023
Q1 		– Sell
-33,000
Closed -$211K – 2333
2022
Q4 		$211K Sell
33,000
-355,600
-92% -$2.68M ﹤0.01% 1255
2022
Q3 		$3.33M Buy
388,600
+12,600
+3% +$162K 0.01% 830
2022
Q2 		$5.11M Buy
376,000
+370,800
+7,131% +$4.79M 0.02% 698
2022
Q1 		$79K Sell
5,200
-378,272
-99% -$5.19M ﹤0.01% 1079
2021
Q4 		$8.77M Buy
+383,472
New +$5.51M 0.04% 546
2021
Q2 		– Sell
-109,200
Closed -$1.44M – 1033
2021
Q1 		$1.44M Buy
+109,200
New +$1.79M 0.01% 770

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Point72 Asset Management's FHTX Position: Q1 2026 in Review

Point72 Asset Management reduced its Foghorn Therapeutics (FHTX) stake by 55% in Q1 2026, selling an estimated $188K and leaving 27,646 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #3580.

Point72 Asset Management first reported a position in FHTX in Q1 2021 and has held it in 18 quarters since. The position peaked at $8.77M in Q4 2021. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Point72 Asset Management held 27,646 shares of Foghorn Therapeutics worth $132K as of Q1 2026.
  • Point72 Asset Management sold 34,322 Foghorn Therapeutics shares in Q1 2026, an estimated $188K.
  • Foghorn Therapeutics made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3580 holding.
  • Point72 Asset Management first reported a position in Foghorn Therapeutics in Q1 2021 and has held it in 18 quarters since.
  • Point72 Asset Management's Foghorn Therapeutics position peaked at $8.77M in Q4 2021.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.